EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 25-Jun-2026 15:15 ET (25-Jun-2026 19:15 GMT/UTC)

Singapore study uncovers why some colorectal cancer tumors return and spread after chemotherapy

Agency for Science, Technology and Research (A*STAR), Singapore
Peer-Reviewed Publication

A study led by researchers from the A*STAR Genome Institute of Singapore (A*STAR GIS), together with the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH), and KU Leuven, Belgium, has uncovered why some colorectal cancer cells become harder to treat and more likely to spread after chemotherapy. Published in Nature Cell Death & Disease, the findings reveal a biological “survival shift” that helps cancer cells withstand treatment and move more aggressively, and point to new ways to identify high-risk patients and potentially improve future treatment strategies.

Journal: Cell Death and Disease

Beating cancer by eating cancer

University of Waterloo
Peer-Reviewed Publication

A research team led by the University of Waterloo is developing a novel tool to treat cancer by engineering hungry bacteria to literally eat tumours from the inside out. Bacteria spores enter the tumour, finding an environment where there are lots of nutrients and no oxygen, which this organism prefers, and so it starts eating those nutrients and growing in size.

Journal: ACS Synthetic Biology

Microplastics discovered in prostate tumors

NYU Langone Health / NYU Grossman School of Medicine
Reports and Proceedings

Small fragments of plastic were found in nine out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds.

Funder: U.S. Department of Defense
Meeting: American Society of Clinical Oncology's Genitourinary Cancers Sympoium.

Human liver tissue cell architecture reconstructed in 3D at a cellular level

University of Washington School of Medicine/UW Medicine
Peer-Reviewed Publication

Never-before-seen 3D reconstructions of human liver tissue have been created at a cellular level. The details capture the spatial microstructure of multiple lobes of this multitasking organ. The reconstructions show how cirrhosis rearranges this intricate architecture and thereby alter the organ's biological activities. In addition, 3D liver maps with a high degree of cellular detail are critical to someday realizing the dream of bioprinting new organs for transplantation.

Funder: NIH Environmental Pathology and Toxicology Training Grant, Howard Hughes Medical Institute, Advanced Research Projects Agency for Health

MSK research highlights, February 23, 2026

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

New research from Memorial Sloan Kettering Cancer Center (MSK) investigates harnessing the power of ferroptosis to spread cell death; reports how an MSK artificial intelligence (AI) model could help improve patient safety; and uses AI to reveal country-specific drivers of global cancer outcomes.

Ochsner MD Anderson uses groundbreaking TIL therapy to treat advanced melanoma in adults

Ochsner Health System
Business Announcement

Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans announces a milestone in advanced cancer treatment, as the first institution in Louisiana to provide an adult patient with tumor-infiltrating lymphocytes (TIL) therapy for advanced melanoma.

Hearing loss contributes to cognitive decline after childhood cancer treatment

St. Jude Children's Research Hospital
Peer-Reviewed Publication

St. Jude Children’s Research Hospital scientists found that hearing loss as a side effect of radiation therapy can increase the risk of cognitive decline.

Journal: Neuro-Oncology

Accelerating next generation medicine with new drug delivery platform

University of Nottingham
Peer-Reviewed Publication

Scientists have developed an adaptable materials platform that can safely and efficiently deliver a wide range of genetic medicines, a breakthrough that could accelerate the development of next‑generation vaccines, cancer treatments, and gene‑silencing drugs.

Journal: Advanced Materials

New support to SPARK Aston University anti-cancer collaboration

Aston University
Grant and Award Announcement

A Royal Orthopaedic Hospital NHS Foundation Trust (ROH) and Aston University collaboration has secured support to develop a minimally invasive anti-cancer and bone regenerative injectable paste, using the cancer-killing properties of gallium.

The team has secured a place on the SPARK THE MIDLANDS programme which aims to provide academic support to advance healthcare research discoveries in the region.

The team from the ROH includes Dr Lucas Souza, Professor Adrian Gardner, and Mr Jonathan Stevenson alongside Professor Richard Martin and Dr Eirini Theodosiou from Aston University. Together, they will use the SPARK programme to secure a route for the cancer-killing paste to be taken from the lab, into clinics and hospitals. If proved effective through clinical trials, the paste - a gallium-doped bioglass - could be used to treat patients with primary and metastatic bone cancer.

mRNA nanobodies show promise in treating colorectal cancer

First Hospital of Jilin University
Peer-Reviewed Publication

Researchers have developed a new mRNA-based immunotherapy that effectively suppresses colorectal cancer in mice. Using lipid nanoparticles to deliver mRNA encoding anti-PD-L1 nanobodies, the treatment reduced tumor growth in both sporadic and colitis-associated colorectal cancer models. The quadruple nanobody format showed superior efficacy by prolonging therapeutic activity and enhancing anti-tumor immunity. This approach represents a promising alternative to conventional antibody therapies, particularly for cancers resistant to current immunotherapies.

Journal: eGastroenterology